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Abstract
Aims There are indications that economic crises can affect public health. The aim of this study was to describe characteris-
tics, health status, and socio-economic status of outpatient heart failure (HF) patients several years after a national economic
crisis and to assess whether socio-economic factors were associated with patient-reported outcome measures (PROMs).
Methods and results In this cross-sectional survey, PROMs were measured with seven validated instruments, as follows:
self-care (the 12-item European Heart Failure Self-Care Behaviour scale), HF-related knowledge (Dutch Heart Failure Knowl-
edge Scale), symptoms (Edmonton Symptom Assessment System), sense of security (Sense of Security in Care—‘Patients’ eval-
uation’), health status (EQ-5D visual analogue scale), health-related quality of life (HRQoL) (Kansas City Cardiomyopathy
Questionnaire), and anxiety and depression (Hospital Anxiety and Depression Scale). Additional data were collected on access
and use of health care, household income, demographics, and clinical status.
The patients’ (n = 124, mean age 73 ± 14.9, 69% male) self-care was low for exercising (53%) and weight monitoring (50%) but
optimal for taking medication (100%). HF-specific knowledge was high (correct answers 12 out of 15), but only 38% knew what
to do when symptoms worsened suddenly. Patients’ sense of security was high (>70% had a mean score of 5 or 6, scale 1–6).
The most common symptom was tiredness (82%); 12% reported symptoms of anxiety, and 18% had symptoms of depression.
Patients rated their overall health (EQ-5D) on average at 65.5 (scale 0–100), and 33% had poor or very bad HRQoL. The
monthly income per household was <€3900 for 84% of the patients. A total of 22% had difficulties making appointments with
a general practitioner (GP), and 5% had no GP. On average, patients paid for six health care-related items, and >90% paid for
medications, primary care, and visits to hospital and private clinics out of their own pocket. The cost of health care had
changed for 71% of the patients since the 2008 economic crisis, and increased out-of-pocket costs were most often explained
by a greater need for health care services and medication expenses. There was no significant difference in PROMs related to
changes in out-of-pocket expenses after the crisis, income, or whether patients lived alone or with others.
Conclusions This Icelandic patient population reported similar health-related outcomes as have been previously reported in
international studies. This study indicates that even after a financial crisis, most of the patients have managed to prioritize and
protect their health even though a large proportion of patients have a low income, use many health care resources, and have
insufficient access to care. It is imperative that access and affordable health care services are secured for this vulnerable
patient population.
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Introduction
Heart failure (HF) is one of the most common and rapidly
increasing public health burdens globally.1 Heart failure ac-
counts for 1–4% of all hospital admissions; consequently,
the burden of HF is costly and is estimated to account for
1–3% of national health expenditure in Western coun-
tries.2,3 In 2012, Iceland spent 9.1% of its gross domestic
product on health. This is comparable with that of the
neighbouring countries with similar health care systems,
such as Sweden, Norway, Finland, and the UK.4 Overall HF
costs were estimated to represent 2.1% of the country’s
total health expenditure, of which 69% were direct costs,
which was slightly more than was estimated globally per
annum (60%). This is similar to the estimated overall HF costs
of the aforementioned countries.4
Chronic HF results in worsening physical and functional ca-
pacities and is characterized by unpredictable and life-
threatening exacerbations and symptoms that often result
in hospital admissions.1 Subsequently, health status domains
such as symptoms, functional limitations, and quality of life
are affected.5,6
The health status of the European population has been
measured regularly, showing that self-reported health status
is worse in the lowest-income groups compared with the
highest-income groups in all countries within the Organisa-
tion for Economic Co-operation and Development (OECD).7
In an economic crisis, such as the one that affected many Eu-
ropean countries in the fall of 2008, people with chronic dis-
eases such as HF might be expected to suffer financially,
potentially leading to a decline in their health status.
The economic crisis in the autumn of 2008 hit many Euro-
pean countries hard. This is evident in the fall of total health
spending in one out of every three OECD countries between
2009 and 2011,7 although there are signs of a slow rise after
2013.8 Since the crisis, per capita health expenditure has de-
creased by 3.8%7 and out-of-pocket costs are currently ap-
proaching 20% of total spending.8 There are indications that
economic crises directly affect the health of the public. For ex-
ample, in the week following the economic collapse in Iceland
in October 2008, visits to cardiac emergency departments in-
creased by 26% than in previous weeks.9 Banking crises are a
significant determinant of short-term increases in heart dis-
ease mortality rates, and may have more severe conse-
quences for developing countries.10 However, little is known
about the long-term effects of economic crises on health.
Multidisciplinary outpatient HF clinics are recommended
for the care of chronic HF patients.1 They can reduce the risk
of unplanned admissions11 and are associated with
favourable cost outcomes.12 To improve outcomes, it is im-
portant to have a clear profile of the patient population and
their need for specialized health care. At times of economic
restraint and limited budget, this is more important than
ever, and the services must be focused and meet patients’
needs. For these purposes, patient-reported outcome mea-
sures (PROMs) are an important aspect of outcomes of clini-
cal trials.13 PROMs are quantified measures of patients’
perspectives regarding symptoms, functional limitations of
diseases, and quality of life.13,14 PROMs include any treat-
ment or outcome evaluation obtained directly from patients
through interviews, self-completed questionnaires, diaries,
or other data collection tools such as hand-held devices and
web-based forms.15
In 2014, Iceland was recovering after the economic crisis,
but there had been considerable cutbacks in the health care
system. The demand for cost-effective care and shorter hospi-
tal stays was constant. Emphasis was therefore on continuing
the development of outpatient hospital clinics and specialized
services within primary health care. To develop HF manage-
ment in these circumstances, a thorough profile of the patient
population was needed. We were interested in studying
the patient population of HF patients who attended a multi-
disciplinary outpatient hospital clinic and in assessing
whether socio-economic factors were associated with PROMs.
Methods
The aim of this study was to describe the characteristics,
health status, and social and economic status of Icelandic
HF patients receiving care from an outpatient HF clinic 6 years
after the national economic crisis in 2008 and, furthermore,
to assess whether socio-economic factors were associated
with PROMs.
In order to describe the patients’ health status in a holistic
and broad context, the Wilson and Cleary model of health-
related quality of life (HRQoL)16 as revised by Ferrans
et al.17 was chosen (Figure 1). The model proposes a classifi-
cation scheme for different measures of health outcomes and
facilitates the understanding of the associations of traditional
clinical variables and health status measures. The model has
been recommended to guide HRQoL research18 and has been
deemed appropriate for use in studies on HF patients.19 Sim-
ilar to Wilson and Cleary,16 we use the terms ‘health status’
and ‘HRQoL’ interchangeably.
Design
This is a cross-sectional study, and data were collected with
mailed questionnaires and from electronic patient records
in the fall of 2014.
Setting
Iceland is one of the Nordic countries, with a population of
335 000. Around two-thirds of the population live in the
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capital Reykjavik and the surrounding areas. Iceland has been
ranked highly in economic, political, and social stability and
equality but was severely hit by the economic crisis in Octo-
ber 2008. In 2013, it was ranked as the 13th most developed
country in the world.20 Iceland’s health care system has uni-
versal coverage for health care costs for most services.21
The study was conducted in Landspítali (the National Uni-
versity Hospital of Iceland), a 600-bed hospital, which runs
the country’s only specialized cardiac unit and an outpatient
HF clinic. The clinic has a multidisciplinary approach to pa-
tient care, which includes assessment of health status, opti-
mization of medication, and self-care education. Patients
can call the clinic if symptoms worsen and can make a
same-day appointment when necessary.
Data collection
A list of all patients registered as clients of the HF clinic when
data collection started was obtained from the Department of
Finance and Information at Landspítali. The survival status of
the 287 registered patients was checked in the Icelandic Pop-
ulation Register. Through the hospital’s patient records sys-
tem, registered patients were also checked to establish
whether they matched the inclusion criteria of the study. In-
clusion criteria for participation were age ≥ 18, able to under-
stand Icelandic, not documented with cognitive impairment,
and able to complete the questionnaires independently or
with help from a family member/friend or a research
assistant.
A total of 227 (79%) patients fulfilled the inclusion criteria
and were mailed an information letter, questionnaire, and a
prepaid return envelope. A reminder phone call was made
1–2 weeks later in order to answer questions and offer assis-
tance with completing the questionnaire. Six patients ac-
cepted such assistance.
Ethical considerations
The study conforms to the principles outlined in the Declara-
tion of Helsinki22 and received approval from the National
Bioethics Committee (14-107-S1), the Data Protection
Authority (2014040651), and the medical chief at LUH. In
the information letter, the participants were informed that
returning a filled-out questionnaire was regarded as consent
to participation.
Measures
Patient-reported outcome measures were measured with
seven previously validated and structured instruments on
self-care, HF-specific knowledge, symptoms, anxiety and de-
pression, sense of security, and HRQoL. Table 1 presents the
instruments and their psychometric properties. Questions
about access and use of health care were adjusted from
Jonsdottir et al.31 Instruments not available in Icelandic were
translated from their original languages to Icelandic and then
back translated. Moreover, in cooperation with the authors,
Figure 1 Conceptual model with the selected patient-reported outcome measures used in the study (revised model of Wilson and Cleary by Ferrans
et al.17 and used with permission from C. E. Ferrans). NYHA, New York Heart Association.
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discrepancies were clarified and the text was changed ac-
cordingly. The whole battery of instruments was then pilot
tested on eight patients who had no major difficulties with
answering the questionnaire.
To characterize the sample, participants answered questions
about their education, employment, marital status, number of
household members and income of the household, and
changes they had experienced in access to health care and
medical costs since the national economic crisis in 2008.
From electronic patient records, the following clinical data
were extracted: previous or current diseases, performed
cardiac procedures, biometrics and pharmacological treatment
(medications), and age, sex, and whether or not duration of
HF was longer than 6 months.
Statistical analysis
Descriptive statistics [mean and standard deviation, frequen-
cies, and proportions (%)] were used to describe the sample
characteristics and the following PROMs: knowledge scores
[Dutch Heart Failure Knowledge Scale (DHFKS)], self-care
[European Heart Failure Self-Care Behaviour scale (EHFScBs)],
sense of security [Sense of Security in Care (SEC)], symptoms
of anxiety and depression [Hospital Anxiety and Depression
Scale (HADS)], quality of life/health status [Kansas City
Cardiomyopathy Questionnaire (KCCQ), EQ-5D visual ana-
logue scale (EQ-5Dvas)], and symptoms [Edmonton Symptom
Assessment System (ESAS)].
Low self-care on the EHFScBs was defined as not agreeing
with the statement (scores 3, 4, and 5). The consulting
behaviour dimension is the mean of four items on seeking
help from health care providers in case of problems.32 The
KCCQ’s overall summary score (OSS) was divided into
quartiles to determine health status. Scores of <25 indicate
the lowest QoL/health status, scores between 25 and 49
indicate poor QoL/health status, scores between 50 and 74
indicate fair QoL/health status, and scores > 75 represent
good QoL/health status.33 Scores of the HADS were divided
with a cut-off point of >7 to distinguish between patients
with symptoms suggestive of anxiety or depression.30
Table 1 Characteristics of the instruments used in the study
Scale/ Subscale
Number
of items Score Responses
Internal consistency
(Cronbach’s alpha)








1 to 5 (completely agree/disagree)
Higher score indicates worse self-care
0.938
Dutch Heart Failure Knowledge Scale (DHFKS)b) 15 0-15 Multiple- choice items, one correct
Higher score indicates more knowledge
0.956
Edmonton Symptom Assessment System (ESAS)c) 10 0-10 10-point scale
(0=None to 10=Worst possible)













(1=Never to 6= Always)
Higher score indicates more sense of
security
0.896
Health status (EQ-VAS)e) 1 0-100 Visual analogue scale
Higher score indicates better health
status


















0-100 Likert scale with 5 - 7 options
Scales are transformed to a range from


















4-point Likert scale Higher scores indicate
more symptoms 0.860
0.821
aEuropean Heart Failure Self-care Scale EHFScBs-12 (Jaarsma et al.23).
bDutch Heart Failure Knowledge Scale (van der Wal et al.24).
cEdmonton Symptom Assessment System ESAS (Richardson and Jones25).
dSense of Security in Care – ‘Patients’ evaluation’ (SEC-P) (Krevers and Milberg26).
eThe health-related quality of life aspects—visual analogue scale (EQ-5Dvas) (Brooks27).
fThe Kansas City Cardiomyopathy Questionnaire (KCCQ) (Green et al.28; Patel et al.29).
gHospital Anxiety and Depression Scale (HADS) (Zigmond and Snaith30).
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Independent t-test, Mann–Whitney U-test, and χ2 test
were used as appropriate, based on normality of data
distribution (Kolmogorov–Smirnov test), to compare PROMs
between those patients whose costs for health care had
changed and not changed since the autumn of 2008
and those with high and low income. Data on self-care and
the OSS of the KCCQ were normally distributed according to
the Kolmogorov–Smirnov test while data on other PROMs
were not.
To prepare data on household income for analysis, the
centre value of each response option was chosen and divided
by the members of the household. The income per person
was categorized into low income [1 = less than 200 000 Ice-
landic króna (ISK) or €1300] (43.4% of sample) and high in-
come (2 = 200 000 ISK and more). The ISK values were
converted to euro by using the currency rate at the time of
data collection. These variables were used to assess the rela-
tionship between income and PROMs.
Missing data were not imputed, and cases were deleted
listwise. The level of statistical significance was set at
<0.05. The software package IBM SPSS-21 statistics was used
for analysis (IBM Corporation, Armonk, NY, USA).
Results
The results are presented in concordance with the model of
PROMs (Figure 1).
Characteristics of the individual
Of 227 eligible patients, 124 accepted the invitation to partic-
ipate in the study (55% response rate). Reminder phone calls
were made, and five of the non-participating patients were
found to be hospitalized and 16 could not be reached. The
mean age and sex of non-participants did not differ from
those of the participants of the study.
The characteristics of the participants are presented in
Table 2. Their mean age was 73 years (±14.9), and 69% were
male. In total, 29% had basic education (9 years) or less, 64%
were retired, and 15% were on disability pension. Most pa-
tients (88%) lived in urban areas in and around the capital,
within 50 km of the hospital.
The mean score of self-care measured with the EHFScBs
was 28.6 (±7.7), and consulting behaviour was 11.0 (±4.6).
Self-care was low in exercising (53%) and weight monitoring
(50%) but optimal in taking medication (100% adherence).
Heart failure-specific knowledge, measured with the
DHFKS, was 11.6 (±3.1), 10 questions were answered
correctly by >80% of patients, and the lowest level of knowl-
edge was found regarding sudden worsening of symptoms
(38% answered correctly) and what to do when thirsty (45%).
Self-efficacy (a measure of how well a patient can manage
her or his care and find answers and help), measured with the
KCCQ, was 85.8 (±18.6), and mastery and identity as mea-
sured with the SEC-P were 5.0 (±0.9) and 5.1 (±0.8), respec-
tively. Over 70% of patients scored 5–6 on the total SEC-P
scale. Lower scores were found in the items ‘Do you have
enough say over your healthcare’ (68%) and ‘Can you do
what is most important to you in your daily life’ (59%).
Biological function
Health status as reflected in biological function and medical
treatment is presented in Table 3. Most of the patients
(96%) had had HF for 6 months or longer. The most common
co-morbidities were atrial fibrillation (62%) and ischaemic
heart disease (61%). A quarter had HF with preserved ejec-
tion fraction (HFpEF), a quarter had HF with mid-range ejec-
tion fraction (HFmrEF), and half of the participants had HF
with reduced ejection fraction (HFrEF).
A total of 46% of patients had undergone revascularization
with either cardiac bypass or percutaneous coronary inter-
vention, 14% had undergone valve surgery, and 64% had im-
planted devices.
Table 2 Patient characteristics (n = 124)
Age in years (mean) (±SD) 73 (±14.9)
Gender (n = 124)
Male 69%
Education (n = 118)
Basic education or less (≤9 years) 29%
Started or completed college 49%
Started or completed university 22%
Employment status (n = 120)








Self-care (n = 115), total score M 28.6 ± 7.7






Heart failure knowledge (n = 124) M 11.6 ± 3.1
Answered correctly
Reasons for HF 77%
Exercise in HF 68%
How often should weigh themselves 67%
What to do about thirst 45%
What to do in case of sudden worsening 38%
Sense of security (n = 123)
Total score M 5.1 ± 0.9
Care M 5.2 ± 0.9
Mastery M 5.0 ± 0.9
Identity M 5.1 ± 0.8
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Overall, patients were on guideline-advised HF medication
with 92% on beta-blockers and 79% on angiotensin-
converting enzyme inhibitors and/or angiotensin receptor
blockers.
Symptoms
Patients reported a median (±SD) prevalence of 5 (range 0–9)
symptoms out of the nine asked about in the ESAS scale. The
most common symptoms were tiredness (82%) and shortness
of breath (77%) (Figure 2). The total symptom score (a com-
bined measure of the symptom scales), measured with the
KCCQ, was 66.1 (±24.6), and on the KCCQ subscales, the
symptom stability score (a measure of whether a patient’s
symptoms are changing over time) was the lowest
55.1(±21.1), while symptom frequency (a measure of how of-
ten a patient has symptoms) was 67.1(±25.7) and symptom
burden (a measure of what the impact of symptoms are on
the patient’s well-being) was 65.2 (±25.0) (Figure 3). The
mean scores of symptoms of anxiety and depression mea-
sured with the HADS were 3.7 (±3.8) and 4.5 (±3.8), respec-
tively. Of the total sample, 12% and 18% had significant
symptoms of anxiety and depression, respectively.
Functional status
Most patients were in New York Heart Association functional
class II (37%) or III (55%), 6% in class I, and 3% in class IV.
Their functional status as measured with the physical limita-
tion score (a measure of how much a patient’s condition is
hampering his or her ability to do what he or she wants to
do) of the KCCQ was 59.5 (±27.6) (Figure 3).
General health perception and overall quality of
life
Patients rated their overall health on average as 65.5 (±22.8)
with the EQ-5Dvas. Quality of life score on KCCQ (a measure
of the overall impact of a patient’s condition on a patient’s in-
terpersonal relationships and state of mind) was 59.3 (±27.4),
and the OSS on KCCQ (a combined measure of all scales) was
61.3 (±23.9) with 67% of patients reporting scores > 50, thus
indicating fair or good QoL/health status (Figure 3).
Characteristics of the environment
Income and household members
The monthly income per person was low, or<€1300 for 43% of
the patients, and the total monthly income of the household
before taxes was<€1950 for 37% of the patients and between
€1950 and €3900 for 47% of patients, while 16% had a house-
hold income> €3900. Around one-third of patients (36%) lived
on their own, 50% lived with another person, and 14% lived in a
household with three or more persons (n = 117).
Social support
Sense of security as it relates to care interaction and measured
with the SEC-P (interaction) was 5.2 (±0.9), and patients scored
on average 59.2 (±30.9) on the KCCQ social limitation scale.
Table 3 Biological function and treatment (n = 124)
Co-morbidities
Atrial fibrillation/flutter 62%
Ischaemic heart disease 61%




Chronic obstructive pulmonary disease 22%
Previous invasive cardiac treatment
Device therapy 40%
Pacemaker 22%
Cardiac resynchronization therapy 9%
Implantable cardioverter defibrillator 9%
Revascularization 36%
PCI 18%










Mineralocorticoid receptor antagonists 41%
Diuretics 94%
Digitalis 24%
Number of other drugs 1–14
ACE-I, angiotensin-converting enzyme inhibitor; ARBs, Angiotensin
II receptor blockers; CABG, coronary artery bypass grafting;
HFmrEF, heart failure with mid-range EF; HFpEF, heart failure with
preserved EF; HFREF, heart failure with reduced EF; PCI, Percutane-
ous coronary intervention.
Figure 2 Frequencies of physical and psychological symptoms on Edmon-
ton Symptom Assessment System (n = 121).
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Cost and access to health care
The cost of health care had changed for 71% of the partici-
pants since the economic crisis in 2008, and the most com-
mon explanations given for increased out-of-pocket costs
were need for more health care services, increased medica-
tion costs, and payment for hospital and clinic visits. On aver-
age, patients paid for 5.5 (±1.4) health care-related items.
The most common expenses were for medication (99%),
appointments at private medical clinics (96%) and health care
centres (95%), and hospital services (93%) (Figure 4).
To make an appointment for necessary health care was
found easy or very easy by 69% of the participants, and
for 92%, it took less than an hour to travel to the most
commonly used health care service. However, 22% said that
it was difficult or almost impossible to make an appoint-
ment with their general practitioner (GP), and 5% did not
have a GP (Table 4).
Relationship between health status and
socio-economic factors
There was no significant difference in any of the PROMs
(self-care, sense of security, knowledge, symptoms of
anxiety and depression, health status, KCCQ clinical sum-
mary score, or KCCQ OSS) between those patients who
perceived they had experienced changes in out-of-pocket
costs since autumn 2008 and those who had not experi-
enced such changes (P > 0.05).
Similarly, no significant difference was found in PROMs be-
tween patients with lower and higher income (P > 0.05).
However, there was a difference in HF knowledge; patients
in the low-income groups had less knowledge than those
with higher incomes (P = 0.016).
No significant difference was found in PROMs between
those patients who lived alone and those living with others,
nor between those who were married/cohabiting and those
who were single, widowed, or divorced.
Discussion
The uniqueness of the study is the fact that it gives a compre-
hensive picture of the complex profile of HF patients in one
Figure 3 Health-related quality of life (KCCQ). (A) Overall summary score divided into quartiles (KCCQ) (n = 124). (B) Scores of the KCCQ scales
(n = 124). KCCQ, Kansas City Cardiomyopathy Questionnaire.
Figure 4 Out-of-pocket expenditure (n = 124).
Table 4 Access to health care (n = 119)












Neither easy nor difficult 25%
Difficult 19%
Almost impossible 3%
I don’t have a GP 5%
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country. The sample size can be estimated to account for
~2.50% of the population of Icelandic HF patients, which is
considerably more than is common in similar survey
studies. We described the health of HF patients who received
care at a multidisciplinary outpatient clinic in the aftermath
of the national economic crisis. In spite of the consequences
of the economic crisis on health care, the results seem to
indicate that patients managed to prioritize and protect
their health.
The participants in our study were quite symptomatic,
with a median of five symptoms on the ESAS scale and typ-
ical symptoms of chronic HF being the most common symp-
toms. Only one other study was found using ESAS in
outpatients with advanced or terminal HF, and participants
in that Italian study were even more symptomatic, with
shortness of breath being present in all participants com-
pared with 77% in our study.34 However, participants’ symp-
toms of anxiety and depression, measured with HADS, were
comparable for depression and better for anxiety than re-
ports from Danish outpatients.35 A report from Ireland, a
country that was also hit hard by the economic crisis, re-
ported a considerably higher prevalence of both depression
and anxiety.36
Patient-reported health status, as measured with the
EQ-5Dvas, was similar (mean 66) to Swedish patients’ health
status from a large Swedish registry study (mean 63) using
data from 2008–13.37 When comparing the health status
of our Icelandic HF patients with the health status of similar
outpatient populations before and after the economic crisis,
the picture is complex. The health status of our patients, as
measured with the KCCQ, was lower than that indicated in
results from both international studies38,39 and an Italian
study using data collected in 2003–0540 but almost identical
to that of an American multicentre study published in
2006.41 In a pilot study on American HF patients after the
crisis, patients reported better health status than did our
population42 while a Belgian HF population on the other
hand showed considerably worse outcomes43 (Table 5). We
do not have Icelandic measures of health status of HF
patients before the economic crisis, but it could be
speculated that the crisis may have affected patients in
the European countries with their universal health care
coverage harder than in patients in the USA with their
private health care coverage. Several European countries
such as Ireland, Spain, Greece, Italy, and Belgium were also
hit hard by the crisis and are still considered countries in
recession.
Patients in this study may have managed their health sit-
uation better despite poor access to primary health care
because they had good access to the outpatient clinic and
to health care in general. This is supported by high scores
on sense of security, where the mean score was of 5.1
out of 6.0 possible. This is the first time that sense of secu-
rity has been measured with this instrument in HF patients,
but their total score was similar to that of samples of pal-
liative cancer patients and outpatient geriatric patients.26,44
Self-care of the patients in this study was found to be sim-
ilar to that of patients in an international study including 15
countries,45 and their knowledge about HF was comparable
with what has been described in previous studies.46,47 How-
ever, it is of concern that only 38% of the patients knew
what to do in the event that their condition worsened. This
may be due to poor knowledge and also confusion regard-
ing access to health care. At the time of the study, acute
cases were referred to hospital emergency departments,
which varied their services for cardiac patients between
weekends and weekdays. This may have caused uncertainty
for patients about the first point of contact when they
needed help. Approximately a quarter of the respondents
reported that they had experienced a change in access to
health care since 2008. While few patients stated they
had experienced improved access after having been diag-
nosed with HF, most described their access as worse. Peo-
ple’s lack of access to primary health care in particular was
also evident in this study, with only 48% of patients finding
it easy or very easy to make an appointment with their GP.
It is important to explain that the health care system in
Iceland was suffering very tight budgets in the years before
2008, and from 2000, constant cutbacks were implemented.
At the same time, a long-standing shortage of GPs in pri-
mary health care continued and only became worse after
the crisis, leading to poor access to the cheapest services.
While on average there were 80 GPs per 100 000 inhabi-
tants within the European Union countries in 2014,
Table 5 Kansas City Cardiomyopathy Questionnaire overall summary scores in comparable studies of outpatient heart failure patients
Study Heidenreich et al.10 Chan et al.38
Network of Nurses of GISSI-HF
and Di Giulio40 Sawadogo et al.43 ICE-HF
Country USA International Italy Belgium Iceland
Year of data collection Not reported 1999–2001 2003–2005 2008–2010 2014
KCCQ OSS quartiles
Worst < 25 9% 3.9% 3.1% 22.3% 8.9%
Poor 25–49 25% 17.3% 12.6% 31.5% 24.2%
Fair 50–74 34% 33.6% 28.2% 27.3% 34.6%
Good 75–100 33% 45.2% 56.1% 18.9% 32.3%
KCCQ, Kansas City Cardiomyopathy Questionnaire; OSS, overall summary score.
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Iceland only had 57.48 This situation makes it difficult to re-
fer acute cases to the health care centres, and the emer-
gency department is subsequently pressured with patients
whose first visit should be elsewhere. This might have
added to the patients’ uncertainty about the first point of
contact when they needed to seek help.
Increased health care costs, especially medication costs,
were reported by most patients. With the fall of the real
exchange rate by 36% between 2007 and 2009,49 the prices
of all imported goods, including medication, rose signifi-
cantly. Out-of-pocket medical expenditure as a proportion
of final household consumption was higher in Iceland
(2.9%) in the year 2013 (or the nearest year) than the
average for the European Union countries (2.3%).50 A new
policy on cost sharing, implemented in 2013, meant a
5.6% increase in out-of-pocket costs for general health care
and a 3.9% increase in medication costs (Ministry of Wel-
fare 2013). To protect the chronically ill, the government
implemented counteractions, which may have worked, as
medication adherence was reported to be 100% in this
study, which is higher than has been measured internation-
ally.45 However, in 2015, patients paid 47% more for an
echocardiogram, 52% more for a visit to a cardiologist,
and 92% more for a blood test (LUH, Division of Economics,
personal communication) than they did before the crisis,
which is of concern. In a study on the impact of the
economic crisis in Iceland on public health behaviour, price
increases were found to explain most of the changes in be-
haviour such as consumption of fruits and vegetables,
smoking, and heavy drinking.51
In spite of the crisis and severe cutbacks in hospital ser-
vices, attempts have been made to protect and improve
the services of the HF outpatient clinic. These seem to have
succeeded in protecting patients and ensuring good access.
Another influencing factor may be that the Icelandic health
care system does not use gatekeepers. This means that pa-
tients have unlimited access to medical specialists in private
practice with partial coverage from the state, and this may
explain why patients are rather content with access to
health care in general. It seems that this patient popula-
tion, who has access to the HF multidisciplinary clinic, is
managing quite well in spite of the increased costs, and
that improved services are covering their needs for health
care contact.
Limitation
This cross-sectional study gives a profile of the HF patient
population in a country hit hard by the economic crisis of
2008. The study does not attempt to explain causality or
associations of variables, as no measures were available
on the patient population’s profile before the crisis. It
therefore remains unknown if the patients’ PROMs were
the same before, or better and declined after the crisis.
The response rate of 55%, although suboptimal, can be
regarded as acceptable for a survey in this patient popula-
tion. The sample was chosen from a registry of patients
cared for by a multidisciplinary outpatient HF clinic, and
the results cannot be generalized beyond that population.
Most of the participants live in the area of the country’s
capital, and it remains unknown how they compare with
other HF patients in the country. Finally, we do not have
information on how long patients had suffered from HF,
as some may have been diagnosed after 2008; therefore,
not only the crisis but also their diagnosis may have
affected both access to and cost of health care.
Conclusions
Six years after the national economic crisis of 2008, a large
proportion of patients with HF have low income and high
health care expenditure. They also report insufficient access
to GPs. Measures to protect important hospital services such
as the HF clinic are therefore vital and seem to have helped
patients to manage their health. It is of great importance that
national health policies serve to protect access and afford-
able health care services for this vulnerable patient
population.
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